Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Argenx Se ADR (ARGX)

Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Argenx Se ADR LAARDERHOOGTWEG 25 AMSTERDAM P7 1101EB NLD

www.argenx.com Employees: 1,599 P: 31-10-703-8441

Sector:

Medical

Description:

argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.

Key Statistics

Overview:

Market Capitalization, $K 52,330,576
Enterprise Value, $K 50,830,636
Shares Outstanding, K 61,569
Annual Sales, $ 2,252 M
Annual Net Income, $ 833,040 K
Last Quarter Sales, $ 1,151 M
Last Quarter Net Income, $ 344,260 K
EBIT, $ 789,230 K
EBITDA, $ 806,760 K
60-Month Beta 0.37
% of Insider Shareholders 2.43%
% of Institutional Shareholders 60.32%
Float, K 60,073
% Float 97.57%
Short Interest 1,860
Short Float 3.02%
Short Volume Ratio 0.41

Growth:

1-Year Return 34.91%
3-Year Return 124.36%
5-Year Return 189.01%
5-Year Revenue Growth 2,334.90%
5-Year Earnings Growth 154.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 5.18 on 10/30/25
Next Earnings Date 02/26/26
Earnings Per Share ttm 13.08
EPS Growth vs. Prev Qtr 38.50%
EPS Growth vs. Prev Year 272.66%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ARGX Ratios

Ratio
Price/Earnings ttm 64.68
Price/Earnings forward 48.04
Price/Earnings to Growth 0.88
Return-on-Equity % 29.78%
Return-on-Assets % 25.81%
Profit Margin % 36.99%
Debt/Equity 0.00
Price/Sales 23.13
Price/Cash Flow 284.78
Price/Book 8.49
Book Value/Share 0.00
Interest Coverage 35.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar